Menu
Sign In Pricing Add Podcast

Sydney Lupkin

Appearances

NPR News Now

NPR News: 01-17-2025 7PM EST

110.424

The type 2 diabetes blockbuster drug is joined by its obesity drug cousin, Wagovi, as well as drugs for various cancers, asthma, psoriasis, and bipolar disorder. The government can't pick just any drugs in Medicare. There are certain rules laid out in the Inflation Reduction Act that say which drugs are eligible. The negotiations will take place in the coming months. Sydney Lufkin, NPR News.

NPR News Now

NPR News: 01-17-2025 7PM EST

96.352

The federal government and the pharmaceuticals industry are about to go head-to-head once again. In its last full weekday in office, the Biden administration has named the next 15 drugs up for price negotiation in Medicare. Ozempic is on the list.